This paper is in the following e-collection/theme issue:

Lung Cancer (29) Patient-Reported Outcome Measures (PROMs) (275) Innovations and Technology in Cancer Care (400) Chemotherapy and Side Effects Management (52)

Published on in Vol 7, No 3 (2021): Jul-Sep

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/26574, first published .
Selecting a Subset Based on the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events for Patient-Reported Symptom Monitoring in Lung Cancer Treatment: Mixed Methods Study

Selecting a Subset Based on the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events for Patient-Reported Symptom Monitoring in Lung Cancer Treatment: Mixed Methods Study

Selecting a Subset Based on the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events for Patient-Reported Symptom Monitoring in Lung Cancer Treatment: Mixed Methods Study

Authors of this article:

Evalien Veldhuijzen1 Author Orcid Image ;   Iris Walraven2 Author Orcid Image ;   José Belderbos1 Author Orcid Image
Article Authors Cited by (5) Tweetations (2) Metrics

Journals

  1. de Rooij B, van den Hurk C, Smaardijk V, Fernandez-Ortega P, Navarro-Martin A, Barberio L, Guckenberger M, Schmid S, Walraven I, Vallow S, Kotsi C, Preusser M, Mosor E, Klok J, Becker A, Milani A, Ninov L, van de Poll-Franse L. Development of an updated, standardized, patient-centered outcome set for lung cancer. Lung Cancer 2022;173:5 View
  2. de Rooij B, van den Hurk C, Smaardijk V, Fernandez-Ortega P, Navarro-Martin A, Barberio L, Guckenberger M, Schmid S, Walraven I, Vallow S, Kotsi C, Preusser M, Mosor E, Klok J, Becker A, Milani A, Ninov L, van de Poll-Franse L. Development of an Updated, Standardized, Patient-Centered Outcome Set for Lung Cancer. SSRN Electronic Journal 2022 View
  3. Veldhuijzen E, Walraven I, Kwint M, Rossi M, Roose L, Janssen T, van de Poll-Franse L, Belderbos J. The Discordance between Patient- and Clinician Reported Outcomes During (Chemo-)Radiation Therapy for Lung Cancer. SSRN Electronic Journal 2022 View
  4. Billingy N, Tromp V, Aaronson N, Hoek R, Bogaard H, Onwuteaka-Philipsen B, van de Poll-Franse L, Hugtenburg J, Belderbos J, Becker-Commissaris A, van den Hurk C, Walraven I, van Walree N, de Jaeger K, Samii S, Lam-Wong W, Koppe F, Stigt J, Herder G, Welling A, Schuurbiers-Siebers O, Smit J, Staal-van den Brekel A, de Jong W. Quality of life after patient-initiated vs physician-initiated response to symptom monitoring: the SYMPRO-Lung trial. JNCI: Journal of the National Cancer Institute 2023;115(12):1515 View
  5. Günther M, Hentschel L, Schuler M, Müller T, Schütte K, Ko Y, Schmidt-Wolf I, Jaehde U. Developing tumor-specific PRO-CTCAE item sets: analysis of a cross-sectional survey in three German outpatient cancer centers. BMC Cancer 2023;23(1) View